retatrutide dosing regimen phase 2 trial Crémieux on X: "I get this question pretty often now: How do I dose to minimize side effects? I asked participants and long-time users, and I reassembled what I think retatrutide dosing schedule phase 2

GLP-1 medication mimics hormones naturally produced in the body that help control appetite, blood sugar, and cravings

The FDA has approved inhaled NAC as an additional treatment to help break down mucus in lung conditions

In these patients, symptoms seem to be caused by abnormal contractions of the circular colonic muscles, which are reduced by GLP-1.79 Indeed, a placebo-controlled trial showed that the GLP-1RA ROSE-010 improved scintigraphically measured colonic transit time in patients with c-IBS.80 Furthermore, high-dose GLP-1 infusion reduced migratory motor complexes and intestinal motility in patients with IBS.77 Data from animal studies suggests that GLP-1RAs also decreases visceral sensitivity.90 In a double-blind randomised prospective trial in humans, pain relief, assessed with a visual analogue score, was higher with ROSE-010, as compared with placebo.91 Since T2DM and IBS frequently coincide, GLP-1RAs might be of double benefit to these patients.92 Short bowel syndrome Malabsorption is a frequent problem in short bowel syndrome, obviously caused by the reduced intestinal absorbent surface

FDA advisory panel weighs access to 7 popular peptides this week

This field of research is referred to as bioenergetics

In phase 2 trials, high-dose retatrutide produced very large weight reductions in adults with obesity, and phase 3 trials are ongoing